363 related articles for article (PubMed ID: 11097467)
1. Relationships between the copper and iron systems in hemodialysis patients and variables affecting these systems.
Kirschbaum B
Biol Trace Elem Res; 2000 Oct; 77(1):13-24. PubMed ID: 11097467
[TBL] [Abstract][Full Text] [Related]
2. Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins.
Gutteridge JM; Quinlan GJ; Mumby S; Heath A; Evans TW
J Lab Clin Med; 1994 Aug; 124(2):263-73. PubMed ID: 8051491
[TBL] [Abstract][Full Text] [Related]
3. The effect of a low-protein diet on serum levels of ceruloplasmin and transferrin in patients with chronic renal failure.
Marecek Z; Vulterinová M; Skála I; Pechar J; Doberský P; Schück O; Nádvorníková H; Heyrovský I
Clin Nephrol; 1978 Jan; 9(1):38-40. PubMed ID: 630743
[TBL] [Abstract][Full Text] [Related]
4. Changes in serum ferritin and other factors associated with iron metabolism during chronic hyperbaric exposure.
Gilman SC; Hunter WL; Mooney LW
Aviat Space Environ Med; 1979 Mar; 50(3):223-6. PubMed ID: 454320
[TBL] [Abstract][Full Text] [Related]
5. Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status.
Van Campenhout A; Van Campenhout C; Lagrou AR; Abrams P; Moorkens G; Van Gaal L; Manuel-y-Keenoy B
Diabetes Metab Res Rev; 2006; 22(6):444-54. PubMed ID: 16506275
[TBL] [Abstract][Full Text] [Related]
6. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
7. Changes of serum iron transferrin and copper ceruloplasmin in rats given Cu(II)2 (acetylsalicylate)4 during acute inflammation.
Ferrari RP; Paradisi L; Torrielli M
Anticancer Res; 1989; 9(3):771-3. PubMed ID: 2548436
[TBL] [Abstract][Full Text] [Related]
8. Serum antioxidant activity in diabetes mellitus.
Jones AF; Winkles JW; Jennings PE; Florkowski CM; Lunec J; Barnett AH
Diabetes Res; 1988 Feb; 7(2):89-92. PubMed ID: 3396268
[TBL] [Abstract][Full Text] [Related]
9. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
[TBL] [Abstract][Full Text] [Related]
10. Alteration in iron metabolism during retinal degeneration in rd10 mouse.
Deleon E; Lederman M; Berenstein E; Meir T; Chevion M; Chowers I
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1360-5. PubMed ID: 18997094
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of the ferroxidase activity of ceruloplasmin during iron loading into ferritin.
Reilly CA; Aust SD
Arch Biochem Biophys; 1997 Nov; 347(2):242-8. PubMed ID: 9367531
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins.
Chauhan A; Chauhan V; Brown WT; Cohen I
Life Sci; 2004 Oct; 75(21):2539-49. PubMed ID: 15363659
[TBL] [Abstract][Full Text] [Related]
14. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
[TBL] [Abstract][Full Text] [Related]
15. Structure and expression of genes involved in transport and storage of iron in red-blooded and hemoglobin-less antarctic notothenioids.
Scudiero R; Trinchella F; Riggio M; Parisi E
Gene; 2007 Aug; 397(1-2):1-11. PubMed ID: 17570620
[TBL] [Abstract][Full Text] [Related]
16. Lens epithelial cells synthesize and secrete ceruloplasmin: effects of ceruloplasmin and transferrin on iron efflux and intracellular iron dynamics.
Harned J; Fleisher LN; McGahan MC
Exp Eye Res; 2006 Oct; 83(4):721-7. PubMed ID: 16806171
[TBL] [Abstract][Full Text] [Related]
17. Reticulocyte hemoglobin content in hemodialysis patients with acute infection.
Mitsuiki K; Harada A; Miyata Y
Clin Exp Nephrol; 2004 Sep; 8(3):257-62. PubMed ID: 15480904
[TBL] [Abstract][Full Text] [Related]
18. [Serum levels of iron, copper, transferrin and ceruloplasmin oxidative activity in chronic circulatory failure].
Bielak J
Pol Tyg Lek; 1971 Oct; 26(43):1654-7. PubMed ID: 5133680
[No Abstract] [Full Text] [Related]
19. Zinc and copper concentration in plasma and erythrocytes of patients with chronic renal failure.
Paniagua-Sierra JR; Pérez-López A; Diaz-Bensussen S; Solís-Alpuche L; Saavedra-Guatemala H; Exaire-Murad JE
Arch Invest Med (Mex); 1981; 12(1):69-82. PubMed ID: 7247613
[TBL] [Abstract][Full Text] [Related]
20. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
